跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ERASER
Authorized
STANDARD
ERASER
the mentholatum company of canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0eb4e2205d969775
Company
the mentholatum company of canada ltd
Type
Standard
Approval Details
Approval Id
0eb4e2205d969775
Drug Approval Canada Name
ERASER
Product Name
ERASER
Status
Cancelled Post Market
Status Date
2020-06-22
Original Market Date
2017-05-31
Din
02457083
Drug Class
Human
Dosage Form
Ointment
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:28.00
Atc Original
D10AE01 BENZOYL PEROXIDE
Atc Name
d 10 ae 01
Aig Number
0107205001
Company Name
the mentholatum company of canada ltd
Company Address
UNIT 205B, 110 Hannover Dr., St. Catharines, Ontario, Canada, L2W 1A4
Active Ingredients
BENZOYL PEROXIDE
5 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0eb4e2205d969775
Type
Standard
Back to Health Canada Approvals
ERASER - Health Canada Drug Approval Details